Note 11 - Revenue

6 Months Ended

Jun. 30, 2019

Notes to Financial Statements

Revenue from Contract with Customer [Text Block]

11 . Revenue

We currently operate as

one

operating segment focusing on biopreservation tools.

The following table disaggregates revenue by market segment and distributors:

	Three Month Period Ended				Six Month Period Ended
	June 30,				June 30,
(In thousands)	2019		2018		2019		2018
Net product sales:
Regenerative medicine	$	3,978	$	2,985	$	6,157	$	5,089
Distributors		2,215		1,695		5,319		2,734
Drug discovery		248		263		486		640
BioBanking		260		235		509		530
Total	$	6,701	$	5,178	$	12,471	$	8,993

 The following table disaggregates revenue by product category:

	Three Month Period Ended				Six Month Period Ended
	June 30,				June 30,
(In thousands)	2019		2018		2019		2018
Net product sales:
Media	$	6,327	$	5,178	$	12,097	$	8,993
Automated thawing products		374		—		374		—
Total	$	6,701	$	5,178	$	12,471	$	8,993